[A case of hyperammonemia presented in a patient with multiple myeloma]

Irina Sjölund1, Peter Kragsbjerg2

  • 1AT-läkare, Region Västmanland.

Lakartidningen
|June 21, 2021
PubMed

Insights

Hyperammonemia-induced encephalopathy is a rare complication of multiple myeloma. Prompt diagnosis and treatment of the underlying cancer are crucial for managing this neurological condition.

Area of Science:

  • Neurology
  • Oncology
  • Nephrology

Background:

  • Multiple myeloma is a plasma cell malignancy.
  • Hyperammonemia-induced encephalopathy is a rare neurological complication.
  • This condition can occur in the absence of liver failure.

Observation:

  • A 78-year-old woman with multiple myeloma presented with acute delirium.
  • Elevated serum ammonia levels were detected.
  • Hepatic function tests were normal.

Findings:

  • The patient's delirium was attributed to hyperammonemia.
  • This suggests a link between multiple myeloma and elevated ammonia levels.
  • Neurological symptoms can manifest without typical signs of liver dysfunction.

Implications:

  • Clinicians should consider hyperammonemia-induced encephalopathy in multiple myeloma patients with unexplained delirium.
  • Effective management requires addressing the underlying multiple myeloma.
  • Early recognition and treatment can improve patient outcomes.

Related Concept Videos

Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.6K
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.2K
Urea Cycle01:23

Urea Cycle

The urea cycle describes how liver cells convert ammonia to urea. Ammonia is a toxic waste product of protein catabolism. Land animals must convert ammonia into the less toxic urea which can be safely eliminated by the kidneys through urine. Marine animals excrete ammonia directly, and the surrounding water dilutes the ammonia to safe levels.
47.5K
Overview of Protein Metabolism01:21

Overview of Protein Metabolism

Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
2.5K